Cargando…

Evaluation of RevX solution extract as a potential inhibitor of the main protease of SARS-CoV-2—In vitro study and molecular docking

The main protease (M(pro)) of SARS-CoV-2 is a protease necessary for viral polyprotein processing and maturation. M(pro) cleaves the polypeptide sequence after the glutamine residues. There is no known cellular protease with this substrate specificity in humans; therefore, it is considered an attrac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chou, Feng-Pai, Liu, Chia-Chun, Huong Giang, Huynh Nguyet, Huang, Sheng-Cih, Hsu, Hsiu-Fu, Wu, Tung-Kung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882484/ https://www.ncbi.nlm.nih.gov/pubmed/35252620 http://dx.doi.org/10.1016/j.heliyon.2022.e09034

Ejemplares similares

Quinazolinone-Peptido-Nitrophenyl-Derivatives as Potential Inhibitors of SARS-CoV-2 Main Protease
por: Giang, Huynh-Nguyet-Huong, et al.
Publicado: (2023)

Rapid prediction of possible inhibitors for SARS-CoV-2 main protease using docking and FPL simulations
por: Pham, Minh Quan, et al.
Publicado: (2020)

Correction: Rapid prediction of possible inhibitors for SARS-CoV-2 main protease using docking and FPL simulations
por: Pham, Minh Quan, et al.
Publicado: (2022)

Chlorhexidine and SARS-CoV-2 main protease: Molecular docking study
por: Grover, Vishakha, et al.
Publicado: (2022)

Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors
por: Cardoso, Wesley B., et al.
Publicado: (2021)

Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease
por: Marinho, Emanuelle Machado, et al.
Publicado: (2020)

Molecular docking identification for the efficacy of natural limonoids against COVID-19 virus main protease
por: de Oliveira, Victor Moreira, et al.
Publicado: (2021)

Molecular docking and dynamics simulation of main protease of SARS-CoV-2 with naproxen derivative
por: K Hussein, Rageh, et al.
Publicado: (2023)

QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease
por: Song, Fucheng, et al.
Publicado: (2023)

Correlation between dissociation and catalysis of SARS-CoV main protease
por: Lin, Pei-Ying, et al.
Publicado: (2008)

Molecular docking analysis of N-substituted Oseltamivir derivatives with the SARS-CoV-2 main protease
por: Belhassan, Assia, et al.
Publicado: (2020)

Discovery of alliin as a putative inhibitor of the main protease of SARS-CoV-2 by molecular docking
por: Cheng, Bijun, et al.
Publicado: (2020)

Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus
por: Odhar, Hasanain Abdulhameed, et al.
Publicado: (2020)

Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations
por: Omer, Samia E., et al.
Publicado: (2022)

Molecular docking reveals the potential of Salvadora persica flavonoids to inhibit COVID-19 virus main protease
por: Owis, Asmaa I., et al.
Publicado: (2020)

An in-solution snapshot of SARS-COV-2 main protease maturation process and inhibition
por: Noske, Gabriela Dias, et al.
Publicado: (2023)

Characterization and epitope mapping of Dengue virus type 1 specific monoclonal antibodies
por: Chen, Wen-Hung, et al.
Publicado: (2017)

Effect of nelfinavir stereoisomers on coronavirus main protease: Molecular docking, molecular dynamics simulation and MM/GBSA study
por: Sargolzaei, Mohsen
Publicado: (2021)

Design, synthesis and docking study of Vortioxetine derivatives as a SARS-CoV-2 main protease inhibitor
por: Suryavanshi, Hemant, et al.
Publicado: (2022)

Molecular docking identification for the efficacy of some zinc complexes with chloroquine and hydroxychloroquine against main protease of COVID-19
por: Hussein, R.K., et al.
Publicado: (2021)

Antiviral peptides against the main protease of SARS-CoV-2: A molecular docking and dynamics study
por: Mahmud, Shafi, et al.
Publicado: (2021)

Docking-based virtual screening and identification of potential COVID-19 main protease inhibitors from brown algae
por: Rauf, Abdur, et al.
Publicado: (2021)

DFT investigations and molecular docking as potent inhibitors of SARS-CoV-2 main protease of 4-phenylpyrimidine
por: Celik, Sibel
Publicado: (2023)

Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking
por: Yang, Xinbo, et al.
Publicado: (2022)

Assessing potential inhibitors of SARS-CoV-2 main protease from available drugs using free energy perturbation simulations
por: Ngo, Son Tung, et al.
Publicado: (2020)

Molecular docking and ADMET study of bioactive compounds of Glycyrrhiza glabra against main protease of SARS-CoV2
por: Srivastava, Vivek, et al.
Publicado: (2022)

SARS-CoV-2 main protease inhibition by compounds isolated from Luffa cylindrica using molecular docking
por: Cao, Thao Quyen, et al.
Publicado: (2021)

Design of new bis-triazolyl structure for identification of inhibitory activity on COVID-19 main protease by molecular docking approach
por: Singh, Gurjaspreet, et al.
Publicado: (2022)

Hunting the main protease of SARS-CoV-2 by plitidepsin: Molecular docking and temperature-dependent molecular dynamics simulations
por: Vishvakarma, Vijay Kumar, et al.
Publicado: (2021)

Chemical reactivities and molecular docking studies of parthenolide with the main protease of HEP-G2 and SARS-CoV-2
por: Ouled Aitouna, Abdelhak, et al.
Publicado: (2021)

Main protease inhibitors and drug surface hotspots for the treatment of COVID-19: A drug repurposing and molecular docking approach
por: Hasan, Mahmudul, et al.
Publicado: (2021)

In silico molecular docking analysis for repurposing approved antiviral drugs against SARS-CoV-2 main protease
por: Khater, Ibrahim, et al.
Publicado: (2021)

RNA-directed remodeling of the HIV-1 protein Rev orchestrates assembly of the Rev–Rev response element complex
por: Jayaraman, Bhargavi, et al.
Publicado: (2014)

Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: A molecular docking and simulation studies
por: Cherrak, Sabri Ahmed, et al.
Publicado: (2020)

Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition
por: Gimeno, Aleix, et al.
Publicado: (2020)

Possible SARS-coronavirus 2 inhibitor revealed by simulated molecular docking to viral main protease and host toll-like receptor
por: Hu, Xiaopeng, et al.
Publicado: (2020)

Repurposing of known anti-virals as potential inhibitors for SARS-CoV-2 main protease using molecular docking analysis
por: Hakmi, Mohammed, et al.
Publicado: (2020)

Identification of Potential Flavonoid Inhibitors of the SARS-CoV-2 Main Protease 6YNQ: A Molecular Docking Study
por: Arora, Sumit, et al.
Publicado: (2020)

Phytochemicals of Rhus spp. as Potential Inhibitors of the SARS-CoV-2 Main Protease: Molecular Docking and Drug-Likeness Study
por: Sherif, Yousery E., et al.
Publicado: (2021)

Synthesis of New Binary Thiazole-Based Heterocycles and Their Molecular Docking Study as COVID-19 Main Protease (M(pro)) Inhibitors
por: Abdel-Latif, E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9pbb1n2au8fqlvidd1greagop0